Image Place holder

Kedar Kirtane, MD

Specialty: Medical Oncology

Program: Head and Neck Oncology

Overview

Dr. Kirtane is interested in working with the Department of Health Outcomes and Behavior and the Department of Cancer Epidemiology to help increase access to cancer care for racial/ethnic minorities with cancer. Dr. Kirtane's research interests also include the development of innovative cellular therapies for solid tumor malignancies.


Associations

    • Head and Neck-Endocrine Oncology
    • Health Outcomes and Behavior
    • Health Outcomes & Behavior Program
    • Health Outcomes & Behavior Program

Education & Training

Board Certification:

  • Internal Medicine

Fellowship:

  • University of Washington, Clinical Fellow - Hematology/Oncology
  • Fred Hutchinson Cancer Research Center, Post Doc - Oncology

Residency:

  • Duke University - Internal Medicine

Medical School:

  • University of Florida - MD
Research

Dr. Kirtane is interested in working with the Department of Health Outcomes and Behavior and the Department of Cancer Epidemiology to help increase access to cancer care for racial/ethnic minorities with cancer. Dr. Kirtane's research interests also include the development of innovative cellular therapies for solid tumor malignancies.

Publications

  • Chung CH, Bonomi M, Steuer CE, Li J, Bhateja P, Johnson M, Masannat J, Song F, Hernandez-Prera JC, Wenig BM, Molina H, Farinhas JM, McMullen CP, Wadsworth JT, Patel KB, Kish JA, Muzaffar J, Kirtane K, Rocco JW, Schell MJ, Saba NF. Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study. Cancers (Basel). 2021 Mar.13(5). Pubmedid: 33803335. Pmcid: PMC7967147.
  • Kirtane K, Elmariah H, Chung CH, Abate-Daga D. Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead. J Immunother Cancer. 2021 Jul.9(7). Pubmedid: 34301811. Pmcid: PMC8311333.
  • Muzaffar J, Bari S, Kirtane K, Chung CH. Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma. Cancers (Basel). 2021 Jan.13(2). Pubmedid: 33477635. Pmcid: PMC7831487.
  • Naffouje SA, Sabesan A, Hallanger-Johnson J, Kirtane K, Gonzalez RJ, Mullinax J. Adrenal biopsy, as a diagnostic method, is associated with decreased overall survival in patients with T1/T2 adrenocortical carcinoma: A propensity score-matched analysis. J Surg Oncol. 2021 Aug. Pubmedid: 34424540.
  • Reckamp KL, Patil T, Kirtane K, Rich TA, Espenschied CR, Weipert CM, Raymond VM, Santana-Davila R, Doebele RC, Baik CS. Duration of Targeted Therapy in Patients With Advanced Non-small-cell Lung Cancer Identified by Circulating Tumor DNA Analysis. Clin Lung Cancer. 2020 Nov.21(6):545-552.e1. Pubmedid: 32665165.
  • Kirtane K, Roth MY. Emerging Therapies for Radioactive Iodine Refractory Thyroid Cancer. CURR TREAT OPTION ON. 2020 Feb.21(3):18. Pubmedid: 32048061.
  • Loggers ET, Kirtane K, Palacios R, Lewis F. Leaving footprints, not scars: a qualitative pilot study of Hispanic mothers' willingness to communicate with dependent children about an advanced cancer diagnosis. Support Care Cancer. 2019 Apr.27(4):1573-1578. Pubmedid: 30719659.
  • Kirtane K, Downey L, Lee SJ, Curtis JR, Engelberg RA. Intensity of End-of-Life Care for Patients with Hematologic Malignancies and the Role of Race/Ethnicity. J Palliat Med. 2018 Oct.21(10):1466-1471. Pubmedid: 29975599. Pmcid: PMC6201780.
  • Buckley SA, Kirtane K, Walter RB, Lee SJ, Lyman GH. Patient-reported outcomes in acute myeloid leukemia: Where are we now?. Blood Rev. 2018 Jan.32(1):81-87. Pubmedid: 28888621.
  • Kirtane K, Rodriguez CP. Postoperative Combined Modality Treatment in High Risk Resected Locally Advanced Squamous Cell Carcinomas of the Head and Neck (HNSCC). Front Oncol. 2018 Dec.8:588. Pubmedid: 30564559. Pmcid: PMC6288294.
  • Kirtane K, Lee SJ. Racial and ethnic disparities in hematologic malignancies. Blood. 2017 Oct.130(15):1699-1705. Pubmedid: 28724539. Pmcid: PMC5639484.

Grants

Title: The feasibility of a digitized peer-to-peer patient support system for patients with locally advanced head and neck cancer undergoing chemoradiation
Sponsor: NCCN
PI: Kirtane, K.